相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
N. Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience
Neil S. Sanghani et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2019)
Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease
Sho Hasegawa et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2018)
HIF-1α promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease
Andre Kraus et al.
KIDNEY INTERNATIONAL (2018)
Current understanding of iron homeostasis
Gregory J. Anderson et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2017)
Real-World Impact of Cardiovascular Disease and Anemia on Quality of Life and Productivity in Patients with Non-Dialysis-Dependent Chronic Kidney Disease
Adrian Covic et al.
ADVANCES IN THERAPY (2017)
Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease
Pablo E. Pergola et al.
KIDNEY INTERNATIONAL (2016)
Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices
Bruce M. Robinson et al.
LANCET (2016)
Differences in the Characteristics of Dialysis Patients in Japan Compared with Those in Other Countries
Naoki Kimata et al.
BLOOD PURIFICATION (2015)
Anaemia in kidney disease: harnessing hypoxia responses for therapy
Mark J. Koury et al.
NATURE REVIEWS NEPHROLOGY (2015)
Prevalence of Anemia in Chronic Kidney Disease in the United States
Melissa E. Stauffer et al.
PLOS ONE (2014)
Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis
Ioannis Koulouridis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Anaemia management and mortality risk in chronic kidney disease
Walter H. Hoerl
NATURE REVIEWS NEPHROLOGY (2013)
Timing and Determinants of Erythropoietin Deficiency in Chronic Kidney Disease
Lucile Mercadal et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD
Wanja M. Bernhardt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Effect of Epoetin Alfa Dose Changes on Hemoglobin and Mortality in Hemodialysis Patients with Hemoglobin Levels Persistently below 11 g/dL
Brian D. Bradbury et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets
Ohidul Siddiqui et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2009)
The impact of analytic method on interpretation of outcomes in longitudinal clinical trials
A. Prakash et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Correction of anemia with epoetin alfa in chronic kidney disease
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
Tilman B. Drueke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Association of kidney function with anemia - The Third National Health and Nutrition Examination Survey (1988-1994)
BC Astor et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
分享论文
